Oncolytics Biotech Stock Price

0.0655 (5.04%)
Upgrade to Real-Time
Regular Market
Volume 136,208
Bid Price 1.36
Ask Price 1.37
News (2)
Day High 1.38


52 Week Range


Day Low 1.29
Company Name Stock Ticker Symbol Market Type
Oncolytics Biotech Inc ONCY NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0655 5.04% 1.365 13:40:10
Open Price Low Price High Price Close Price Prev Close
1.38 1.29 1.38 1.2995
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
372 136,208 $ 1.35 $ 183,970 - 0.8021 - 2.381
Last Trade Time Type Quantity Stock Price Currency
13:40:10 533 $ 1.365 USD


Draw Mode:

Oncolytics Biotech Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 78.88M 57.79M 57.03M $ - $ - - -3.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

Oncolytics Biotech News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ONCY Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.241.381.211.26163,0120.12510.08%
1 Month1.001.380.9611.16112,1560.36536.5%
3 Months1.091.380.80211.05122,8490.27525.23%
6 Months2.022.040.80211.37148,219-0.655-32.43%
1 Year2.172.3810.80211.69228,447-0.805-37.1%
3 Years0.906.020.3512.59735,7680.46551.67%
5 Years5.857.400.3512.60551,308-4.49-76.67%

Oncolytics Biotech Description

Oncolytics Biotech Inc is a development-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives. The company's product pipeline includes Bavencio, Keytruda, Retifanlimab, and Tecentriq.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now